Traducción del inglés-

During the past decade, Complejo Hospitalario de Pontevedra conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 8 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 7 clinical trials were completed. i.e. 28% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario de Pontevedra" #1 sponsor was "PETHEMA Foundation" with 6 trials, followed by "Takeda" with 6 trials sponsored, "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 4 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Pontevedra" #1 collaborator was "Celgene" with 2 trials as a collaborator, "Dynamic Science S.L." with 2 trials as a collaborator, "Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud" with 2 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator and "Adknoma" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Pontevedra" are "Crohn's Disease" (5 trials), "Advanced Prostate Cancer" (4 trials), "Crohn Disease" (4 trials), "Complex Perianal Fistula" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Complejo Hospitalario de Pontevedra" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario de Pontevedra" are "Drug" (42 trials), "Biological" (4 trials), "Other" (4 trials), "Procedure" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Dexamethasone" (4 trials), "Bortezomib" (2 trials), "Darvadstrocel" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario de Pontevedra" are 56 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Complejo Hospitalario de Pontevedra". 2 are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Complejo Hospitalario de Pontevedra, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario de Pontevedra, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".